Pfizer settles largest ever fraud suit for off-label promotion

被引：0
|
作者：
Mark Ratner
机构：
来源：
Nature Biotechnology | 2009年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：961 / 962
页数：1
相关论文
共 50 条
  • [21] The Law and Practice of Off-Label Prescribing and Physician Promotion
    Syed, Shariful A.
    Dixson, Brigham A.
    Constantino, Eduardo
    Regan, Judith
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW, 2021, 49 (01): : 53 - 59
  • [22] Pros and cons of off-label promotion investigations and prosecutions
    Loucks, Michael K.
    [J]. FOOD AND DRUG LAW JOURNAL, 2006, 61 (03) : 577 - 583
  • [23] Brain Wellness "Spas"-Anticipating the Off-label Promotion of Psychedelics
    Wexler, Anna
    Sisti, Dominic
    [J]. JAMA PSYCHIATRY, 2022, 79 (08) : 748 - 749
  • [24] FDA Regulation of Off-label Drug Promotion Under Attack
    Kesselheim, Aaron S.
    Mello, Michelle M.
    Avorn, Jerry
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (05): : 445 - 446
  • [25] Reforming Off-Label Promotion to Enhance Orphan Disease Treatment
    Liang, Bryan A.
    Mackey, Tim
    [J]. SCIENCE, 2010, 327 (5963) : 273 - 274
  • [26] Shifting Terrain in the Regulation of Off-Label Promotion of Pharmaceuticals.
    Mello, Michelle M.
    Studdert, David M.
    Brennan, Troyen A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (15): : 1557 - 1566
  • [27] An Uninformative Truth: The Logic of Amarin's Off-Label Promotion
    Hey, Spencer Phillips
    Kesselheim, Aaron S.
    [J]. PLOS MEDICINE, 2016, 13 (03)
  • [28] Off-Label Promotion of Transcranial Magnetic Stimulation on Provider Websites
    Wexler, Anna
    Nagappan, Ashwini
    Kopyto, Deena
    Santarnecchi, Emiliano
    Pascual-Leone, Alvaro
    [J]. BRAIN STIMULATION, 2021, 14 (03) : 723 - 724
  • [29] Off-Label Promotion: Government Theories of Prosecution and Facts That Drive Them
    Burroughs, Allison D.
    Levy, Mark Carlisle
    Schwab, Gregory G.
    Paik, Young
    [J]. FOOD AND DRUG LAW JOURNAL, 2010, 65 (03) : 555 - 588
  • [30] DRUG MARKETING Off-label marketing: free speech or illegal promotion?
    Silverman, Ed
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
12345